chr19-48635684-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001352.5(DBP):c.446C>T(p.Ala149Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000984 in 1,321,384 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001352.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DBP | NM_001352.5 | c.446C>T | p.Ala149Val | missense_variant | 2/4 | ENST00000222122.10 | NP_001343.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DBP | ENST00000222122.10 | c.446C>T | p.Ala149Val | missense_variant | 2/4 | 1 | NM_001352.5 | ENSP00000222122.4 | ||
DBP | ENST00000601104.1 | c.446C>T | p.Ala149Val | missense_variant | 2/3 | 1 | ENSP00000469291.1 | |||
DBP | ENST00000594723.1 | n.765C>T | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151994Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000549 AC: 1AN: 1822Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 1072
GnomAD4 exome AF: 0.000103 AC: 120AN: 1169390Hom.: 0 Cov.: 32 AF XY: 0.000106 AC XY: 60AN XY: 565750
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151994Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74268
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.446C>T (p.A149V) alteration is located in exon 2 (coding exon 2) of the DBP gene. This alteration results from a C to T substitution at nucleotide position 446, causing the alanine (A) at amino acid position 149 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at